These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 6272920

  • 1. Inhibition of central angiotensin I conversion by oral captopril.
    Marson O, Ribeiro AB, Tufik S, Kohlmann O, Ramos OL.
    Braz J Med Biol Res; 1981 Apr; 14(1):73-6. PubMed ID: 6272920
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
    Baum T, Becker FT, Sybertz EJ.
    Life Sci; 1983 Mar 21; 32(12):1297-303. PubMed ID: 6300578
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of enalapril, enalaprilic acid and captopril in blocking angiotensin I-induced pressor and dipsogenic responses in spontaneously hypertensive rats.
    Gaul SL, Martin GE, Sweet CS.
    Clin Exp Hypertens A; 1984 Mar 21; 6(6):1187-206. PubMed ID: 6086183
    [Abstract] [Full Text] [Related]

  • 4. Studies on the mechanism of captopril induced hypotension in rats.
    Clarke DE, Wagner LB, Wagner LA.
    Res Commun Chem Pathol Pharmacol; 1981 Jan 21; 31(1):13-30. PubMed ID: 7020011
    [Abstract] [Full Text] [Related]

  • 5. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats.
    Suzuki M, Satoh S.
    Arch Int Pharmacodyn Ther; 1981 Sep 21; 253(1):121-36. PubMed ID: 6275810
    [Abstract] [Full Text] [Related]

  • 6. Effect of captopril on the blood pressure response to angiotensin I in turkeys.
    Fregly MJ, Simpson CF, Palmore WP.
    Proc Soc Exp Biol Med; 1981 Jan 21; 166(1):35-8. PubMed ID: 6258174
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y, Di Nicolantonio R, Hutchinson JS.
    Clin Exp Pharmacol Physiol Suppl; 1982 Jan 21; 7():129-34. PubMed ID: 6183035
    [Abstract] [Full Text] [Related]

  • 8. Relationship between inhibition of pressor response to angiotensin I and blood concentration of captopril following a single oral administration to dogs.
    Koike H, Ikeda T, Komai T, Kawai K, Miyamota M, Shindo H.
    Eur J Pharmacol; 1981 Feb 19; 69(4):447-51. PubMed ID: 6265226
    [Abstract] [Full Text] [Related]

  • 9. Effects of an orally active converting-enzyme inhibitor, SQ 14225, on pressor responses to angiotensin administered into the brain ventricles of spontaneously hypertensive rats.
    Mann JF, Rascher W, Dietz R, Schömig A, Ganten D.
    Clin Sci (Lond); 1979 Jan 19; 56(6):585-9. PubMed ID: 383371
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J, Koga T, Yamazaki T, Shiraki Y, Sakai K.
    Arch Int Pharmacodyn Ther; 1988 Jan 19; 292():203-22. PubMed ID: 3293542
    [Abstract] [Full Text] [Related]

  • 11. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats.
    Unger T, Kaufmann-Bühler I, Schölkens B, Ganten D.
    Eur J Pharmacol; 1981 Apr 09; 70(4):467-78. PubMed ID: 6263638
    [Abstract] [Full Text] [Related]

  • 12. Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats.
    Vollmer RR, Boccagno JA.
    Eur J Pharmacol; 1977 Sep 15; 45(2):117-25. PubMed ID: 198216
    [Abstract] [Full Text] [Related]

  • 13. Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain.
    Evered MD, Robinson MM, Richardson MA.
    Eur J Pharmacol; 1980 Dec 19; 68(4):443-9. PubMed ID: 6258934
    [Abstract] [Full Text] [Related]

  • 14. Dissociation between in vivo and in vitro measurements of converting enzyme activity after chronic oral treatment with captopril in rats.
    Unger T, Hübner D, Schüll B, Yukimura T, Rascher W, Lang RE, Ganten D.
    Am J Cardiol; 1982 Apr 21; 49(6):1530-2. PubMed ID: 6280482
    [Abstract] [Full Text] [Related]

  • 15. Renin dependence of captopril-induced drinking after ureteric ligation in the rat.
    Elfont RM, Fitzsimons JT.
    J Physiol; 1983 Oct 21; 343():17-30. PubMed ID: 6358461
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA, de Bruyn JH, Wenting GJ, Man in 't Veld AJ, Derkx FH.
    Ned Tijdschr Geneeskd; 1980 Nov 22; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract] [Full Text] [Related]

  • 18. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
    Cohen ML, Kurz KD.
    J Pharmacol Exp Ther; 1982 Jan 22; 220(1):63-9. PubMed ID: 6273529
    [No Abstract] [Full Text] [Related]

  • 19. Interactions of the systemic and brain renin-angiotensin systems in the control of drinking and the central mediation of pressor responses.
    Robinson MM, McLennan GP, Thunhorst RL, Johnson AK.
    Brain Res; 1999 Sep 18; 842(1):55-61. PubMed ID: 10526095
    [Abstract] [Full Text] [Related]

  • 20. Chronic captopril infusion in two-kidney, one clip rats with normal plasma renin concentration.
    Wallace EC, Morton JJ.
    J Hypertens; 1984 Jun 18; 2(3):285-9. PubMed ID: 6099389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.